Authors/Disclosures
|
John A. Messenheimer, Jr., MD
|
Dr. Messenheimer has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Zynerba Pharmaceuticals. Dr. Messenheimer has received intellectual property interests from a discovery or technology relating to health care. Dr. Messenheimer has received intellectual property interests from a discovery or technology relating to health care. Dr. Messenheimer has received intellectual property interests from a discovery or technology relating to health care. |
|
Hee-Kwon Park, MD
(Seoul National University Hospital)
|
No disclosure on file |
|
Marianne C. Cunnington, PhD
(GlaxoSmithKline)
|
No disclosure on file |
|
Robert G. Smith, MD, PhD
(Methodist Neurological Institute)
|
Dr. Smith has nothing to disclose. |